Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT00696111

NCT00696111
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You have been diagnosed with Polycystic Ovary Syndrome (PCOS)
  • You are obese, meaning your Body Mass Index (BMI) is 30 or higher

Who may not be able to join:

  • You have been diagnosed with certain hormonal or glandular conditions, such as a specific type of adrenal disorder (nonclassic 21-hydroxylase deficiency), Cushing syndrome, an underactive thyroid, or significantly high levels of a hormone called prolactin
  • You have taken steroid medications (including birth control pills), medications that affect how your body handles blood sugar, or medications known to affect sleep, within the 2 months before the study starts
  • You are currently pregnant (based on a positive pregnancy test)
  • You have been diagnosed with diabetes
  • You have high blood pressure (above 140/90 mmHg) that is not well-controlled with either ACE inhibitor or diuretic medications
  • You regularly drink alcohol
  • You consume more than 300 mg of caffeine per day (roughly 2–3 cups of coffee)
  • You have a known allergy to peanuts or to any medications used in this study
  • Your blood count is low, specifically if your hemoglobin is below 11 g/dL or your hematocrit is below 33% (confirm with trial site)
  • You have a serious ongoing illness affecting your heart, kidneys, liver, or you have been diagnosed with cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
University of Chicago
Registry
clinicaltrials_gov
Start date
1 December 2007
Est. completion
30 June 2022

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Estrogen Levels; Sleep Efficiency Measured at Baseline; Total Testosterone

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov